Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods
Authors:
- Betül ToprakBTBetül Toprak
- Jan BredereckeJBJan Brederecke
- Francesco GianfagnaFrancesco Gianfagna
- Julie K K Vishram-NielsenJVJulie K K Vishram-Nielsen
- Francisco M OjedaFOFrancisco M Ojeda
- Simona CostanzoSCSimona Costanzo
- Christin S BörschelCBChristin S Börschel
- Stefan SöderbergSSStefan Söderberg
- Stephan CamenSCStephan Camen
- Erkki VartiainenEVErkki Vartiainen
Open Access
- 4 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (3) , 812-819
Abstract
To identify robust circulating predictors for incident atrial fibrillation (AF) using classical regressions and machine learning (ML) techniques within a broad spectrum of candidate variables. In pooled European community cohorts (n = 42 280 individuals), 14 routinely available biomarkers mirroring distinct pathophysiological pathways including lipids, inflammation, renal, and myocardium-specific markers (N-terminal pro B-type natriuretic peptide [NT-proBNP], high-sensitivity troponin I [hsTnI]) were examined in relation to incident AF using Cox regressions and distinct ML methods. Of 42 280 individuals (21 843 women [51.7%]; median [interquartile range, IQR] age, 52.2 [42.7, 62.0] years), 1496 (3.5%) developed AF during a median follow-up time of 5.7 years. In multivariable-adjusted Cox-regression analysis, NT-proBNP was the strongest circulating predictor of incident AF [hazard ratio (HR) per standard deviation (SD), 1.93 (95% CI, 1.82–2.04); P < 0.001]. Further, hsTnI [HR per SD, 1.18 (95% CI, 1.13–1.22); P < 0.001], cystatin C [HR per SD, 1.16 (95% CI, 1.10–1.23); P < 0.001], and C-reactive protein [HR per SD, 1.08 (95% CI, 1.02–1.14); P = 0.012] correlated positively with incident AF. Applying various ML techniques, a high inter-method consistency of selected candidate variables was observed. NT-proBNP was identified as the blood-based marker with the highest predictive value for incident AF. Relevant clinical predictors were age, the use of antihypertensive medication, and body mass index. Using different variable selection procedures including ML methods, NT-proBNP consistently remained the strongest blood-based predictor of incident AF and ranked before classical cardiovascular risk factors. The clinical benefit of these findings for identifying at-risk individuals for targeted AF screening needs to be elucidated and tested prospectively. AMDMS, Averaged minimal depth of a maximal subtree; BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-density lipoprotein; HF, heart failure; LASSO, Least absolute shrinkage and selection operator; LDL, low-density lipoprotein; LOD, limit of detection; MI, myocardial infarction; NT-proBNP, N-terminal pro B-type natriuretic peptide; RSF, Random survival forest; VIMP, variable importance.Keywords
Funding Information
- European Research Council
- European Union’s Horizon 2020 (648131, 847770)
- German Center for Cardiovascular Research (81Z1710103, 81Z0710114)
- German Ministry of Research and Education (01ZX1408A, 031L0239, BMH4-CT98-3183, QLG2-CT-2002-01254, HEALTH-F4-2007-201413, HEALTH-F3-2010-242244, HEALTH-F2-2011-278913, 825903)
- Medical Research Council, London (G0601463, 80983)
- MORGAM Data Centre
- MORGAM Laboratories
- MORGAM Participating Centres
- National Institute for Health and Welfare
- Finnish Foundation for Cardiovascular Research
- Emil Aaltonen Foundation
- Research Council of Finland (321351, European Union)
- Swedish Heart and Lung Foundation
- Ministero della Salute
This publication has 17 references indexed in Scilit:
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort studyThe Lancet, 2015
- Paradoxical Association of Lipoprotein Measures With Incident Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2014
- B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studiesEP Europace, 2014
- Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillationAmerican Heart Journal, 2014
- N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicityHeart, 2013
- Blood Lipid Levels, Lipid-Lowering Medications, and the Incidence of Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2012
- mice: Multivariate Imputation by Chained Equations inRJournal of Statistical Software, 2011
- Extensions of net reclassification improvement calculations to measure usefulness of new biomarkersStatistics in Medicine, 2010
- High-Dimensional Variable Selection for Survival DataJournal of the American Statistical Association, 2010
- Inference and missing dataBiometrika, 1976